Nicholas Dembitsky

Nicholas Dembitsky practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Nicholas Dembitsky's NPI, 1205199924, was assigned on June 18, 2012. Nicholas Dembitsky graduated from Universidad Autonoma de Guadalajara in 2012. Nicholas Dembitsky's Arizona license number on file is R73409.

Nicholas Dembitsky's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Nicholas Dembitsky's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Nicholas Dembitsky to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nicholas Dembitsky practices. Vendor and product names are available with a free account.

Internal medicine is Nicholas Dembitsky's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Nicholas Dembitsky is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Nicholas Dembitsky's licenses on file in 2 states: Arizona and California.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, aneurysm, anxiety, atrial fibrillation and flutter, bursitis and carpal tunnel syndrome among the conditions Nicholas Dembitsky treats.

CMS data shows 308 Medicare services from Nicholas Dembitsky across 4 procedure codes in 2024, for 147 Medicare patients. Medicare paid $24,190 for them. Every service was in an office.

CMS counts 147 Medicare patients who saw Nicholas Dembitsky in 2024. The largest group is 65 to 74, with 70 patients. 58% of them have high cholesterol, and 57% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Nicholas Dembitsky's median patient age at 59, with 45% women.

In 2024, Nicholas Dembitsky wrote 5,741 Medicare Part D claims for 610 patients. 86% of them were for generic drugs. CMS names the drug for 4,983 of them, across 103 drugs with 11 or more claims each, at $476,927 in total drug cost. In 2023, CMS named 4,661 claims across 99 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Nicholas Dembitsky for performance year 2024, reported as part of a group. Nicholas Dembitsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nicholas Dembitsky as offering telehealth.

CMS Open Payments shows 1 general payment to Nicholas Dembitsky from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $13.

Nicholas Dembitsky graduated from Universidad Autonoma de Guadalajara in 2012.

Nicholas Dembitsky is in network with 6 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.